Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase
BACE is an enzyme necessary for the generation of neurotoxic amyloid-β in Alzheimer's disease. Claes Wahlestedt and his colleagues identify a noncoding RNA that is upregulated in the brains of individuals with Alzheimer's disase. This noncoding RNA increases expression of BACE, driving amy...
Uložené v:
| Vydané v: | Nature medicine Ročník 14; číslo 7; s. 723 - 730 |
|---|---|
| Hlavní autori: | , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
New York
Nature Publishing Group US
01.07.2008
Nature Publishing Group |
| Predmet: | |
| ISSN: | 1078-8956, 1546-170X, 1546-170X |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Shrnutí: | BACE is an enzyme necessary for the generation of neurotoxic amyloid-β in Alzheimer's disease. Claes Wahlestedt and his colleagues identify a noncoding RNA that is upregulated in the brains of individuals with Alzheimer's disase. This noncoding RNA increases expression of BACE, driving amyloid-β generation and possibly disease progression.
Recent efforts have revealed that numerous protein-coding messenger RNAs have natural antisense transcript partners, most of which seem to be noncoding RNAs. Here we identify a conserved noncoding antisense transcript for β-secretase-1 (
BACE1
), a crucial enzyme in Alzheimer's disease pathophysiology. The BACE1-antisense transcript (
BACE1
-AS) regulates
BACE1
mRNA and subsequently BACE1 protein expression
in vitro
and
in vivo
. Upon exposure to various cell stressors including amyloid-β 1–42 (Aβ 1–42), expression of
BACE1
-AS becomes elevated, increasing
BACE1
mRNA stability and generating additional Aβ 1–42 through a post-transcriptional feed-forward mechanism.
BACE1
-AS concentrations were elevated in subjects with Alzheimer's disease and in amyloid precursor protein transgenic mice. These data show that
BACE1
mRNA expression is under the control of a regulatory noncoding RNA that may drive Alzheimer's disease–associated pathophysiology. In summary, we report that a long noncoding RNA is directly implicated in the increased abundance of Aβ 1–42 in Alzheimer's disease. |
|---|---|
| Bibliografia: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ISSN: | 1078-8956 1546-170X 1546-170X |
| DOI: | 10.1038/nm1784 |